Skip to content
healthcare.dev

Docetaxel

NDC 0409-2026, DOCETAXEL ANHYDROUS, injection, solution, from Hospira, Inc..

Product NDC
0409-2026
Status
Listed
Labeler
Hospira, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022234
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0409-2026 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOCETAXEL ANHYDROUS10 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
0409-2026-01004092026011 VIAL, SINGLE-DOSE in 1 CARTON (0409-2026-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/00c61d11-d6b7-4618-b6f6-2592dbcc8af7
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0409-2026

Use it

Look up 0409-2026 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0409-2026 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0409-2026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.